Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

HK Stock Market Move | ORBUSNEICH(06929) rose nearly 6% last year, with a 5.49% year-on-year increase in net profit. Revenue reached a five-year high.

CICC: Acceleration of Global Electrification, Focus on the Temporary Rebound Opportunity of the Passenger Car Sector.

HK Stock Market Move | STARPLUS LEGEND (06683) rose more than 24% in the afternoon, with an annual loss of over 52 million yuan, turning from profit to loss. The company said it is currently undergoing business structure and strategic upgrades.
HK Stock Market Move | ORBUSNEICH(06929) rose nearly 6% last year, with a 5.49% year-on-year increase in net profit. Revenue reached a five-year high.

CICC: Acceleration of Global Electrification, Focus on the Temporary Rebound Opportunity of the Passenger Car Sector.

HK Stock Market Move | STARPLUS LEGEND (06683) rose more than 24% in the afternoon, with an annual loss of over 52 million yuan, turning from profit to loss. The company said it is currently undergoing business structure and strategic upgrades.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


